JPMORGAN CHASE & CO - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$111,991
-68.5%
129,784
-1.5%
0.00%
Q2 2023$355,706
-88.7%
131,743
-21.7%
0.00%
Q1 2023$3,140,000
+108776.6%
168,292
-6.5%
0.00%
Q4 2022$2,884
-99.8%
180,054
+26.9%
0.00%
Q3 2022$1,846,000
+22.5%
141,871
-0.5%
0.00%
Q2 2022$1,507,000
+2.7%
142,631
+16.8%
0.00%
Q1 2022$1,468,000
-16.1%
122,162
-1.6%
0.00%
Q4 2021$1,750,000
-86.6%
124,090
-90.3%
0.00%
-100.0%
Q3 2021$13,030,000
-78.2%
1,274,966
-43.3%
0.00%
-71.4%
Q2 2021$59,870,000
-20.9%
2,248,233
+3.2%
0.01%
-30.0%
Q1 2021$75,647,000
-1.4%
2,179,430
+5.4%
0.01%
-9.1%
Q4 2020$76,723,000
-4.5%
2,068,574
+7.2%
0.01%
-15.4%
Q3 2020$80,327,000
+11.5%
1,930,034
+8.6%
0.01%
-7.1%
Q2 2020$72,021,000
+23.3%
1,776,999
+5.7%
0.01%0.0%
Q1 2020$58,427,000
-25.4%
1,681,344
-7.9%
0.01%
-6.7%
Q4 2019$78,333,000
+18.0%
1,826,348
+1.7%
0.02%
+15.4%
Q3 2019$66,379,000
-11.6%
1,794,994
+6.5%
0.01%
-13.3%
Q2 2019$75,115,000
+12.1%
1,686,079
+36.8%
0.02%
+7.1%
Q1 2019$66,989,000
+20.8%
1,232,560
+2.9%
0.01%
+7.7%
Q4 2018$55,443,000
-21.2%
1,198,003
+3.4%
0.01%0.0%
Q3 2018$70,378,000
+5.9%
1,158,474
+9.1%
0.01%
-7.1%
Q2 2018$66,444,000
+49.1%
1,061,404
+10.1%
0.01%
+40.0%
Q1 2018$44,553,000
-10.1%
964,366
-7.7%
0.01%0.0%
Q4 2017$49,547,000
-8.4%
1,045,295
+3.3%
0.01%
-16.7%
Q3 2017$54,110,000
+56.5%
1,012,338
-5.5%
0.01%
+50.0%
Q2 2017$34,586,000
+23.4%
1,070,781
-5.8%
0.01%
+33.3%
Q1 2017$28,017,000
+23.2%
1,136,547
+7.0%
0.01%
+20.0%
Q4 2016$22,732,000
+2.0%
1,062,223
-1.4%
0.01%0.0%
Q3 2016$22,294,000
+5.9%
1,077,009
-16.0%
0.01%0.0%
Q2 2016$21,051,000
-22.7%
1,282,804
+0.3%
0.01%
-28.6%
Q1 2016$27,236,000
-49.0%
1,279,322
-27.1%
0.01%
-46.2%
Q4 2015$53,438,000
+51.8%
1,753,815
+9.2%
0.01%
+44.4%
Q3 2015$35,211,000
-6.6%
1,606,351
+0.2%
0.01%0.0%
Q2 2015$37,679,000
+149.8%
1,603,332
+233.5%
0.01%
+200.0%
Q1 2015$15,086,000
-27.6%
480,756
-37.0%
0.00%
-40.0%
Q4 2014$20,851,000762,6460.01%
Other shareholders
FIBROGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders